Purple Biotech (PPBT) Interest Coverage Ratio (2014 - 2026)
Purple Biotech's (PPBT) quarterly Interest Coverage Ratio came in at 72.61 in Q1 2026, up 80.76% year-on-year from 40.17 in Q1 2025, and down 33.72% on a QoQ basis from 109.56 in Q4 2025.
Purple Biotech (PPBT) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 12 years of Interest Coverage Ratio data on file, last reported at 72.61 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 80.76% year-over-year to 72.61 in Q1 2026; TTM through Mar 2026 was 147.4, a 821.57% increase from a year earlier, with the FY2025 full-year figure at 27.96, up 22.72% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 72.61, down from 109.56 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for PPBT reached as high as 359.19 in Q3 2023 and fell as low as 366.72 in Q4 2022.
- Historically, Interest Coverage Ratio has averaged 91.44 across 5 years, with a median of 72.61 in 2026.
- Across the five-year window, Interest Coverage Ratio sank 590.82% in 2024 and jumped 6449.81% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 366.72 in 2022, then jumped by 100.82% to 3.0 in 2023, then sank by 590.82% to 14.72 in 2024, then jumped by 844.06% to 109.56 in 2025, then plunged by 33.72% to 72.61 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 72.61 in Q1 2026, 109.56 in Q4 2025, and 273.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - | 72.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.61 |
| Dec 31, 2025 | 109.56 |
| Sep 30, 2025 | 273.40 |
| Jun 30, 2025 | -21.31 |
| Mar 31, 2025 | 40.17 |
| Dec 31, 2024 | -14.72 |
| Sep 30, 2024 | 4.17 |
| Jun 30, 2024 | 144.08 |
| Mar 31, 2024 | 262.71 |
| Dec 31, 2023 | 3.00 |
| Sep 30, 2023 | 359.19 |
| Jun 30, 2023 | 34.70 |
| Mar 31, 2023 | 86.81 |
| Dec 31, 2022 | -366.72 |
| Sep 30, 2022 | 317.56 |
| Jun 30, 2022 | 70.39 |
| Mar 31, 2022 | 178.80 |
| Dec 31, 2021 | 86.46 |
| Sep 30, 2021 | 144.86 |
| Jun 30, 2021 | 35.51 |